<DOC>
	<DOCNO>NCT00602160</DOCNO>
	<brief_summary>The increase prevalence allergic diseases westernized country pose significant health problem tremendous burden quality life healthcare expenditure . Food allergy affect many 6 % young child 3 % 4 % adult . While majority child outgrow allergy milk , egg , wheat soy , allergy peanut , tree nut , fish shellfish often life-long . Currently , treatments cure provide long-term remission food allergy . Based preliminary study , hypothesize investigational botanical drug , FAHF-2TM , safe effective herbal therapy food allergy . We enrol age 12-45 yr old allergy peanut , tree nut , sesame , fish , and/or shellfish .</brief_summary>
	<brief_title>Therapeutic Effect Chinese Herbal Medicine Food Allergy</brief_title>
	<detailed_description>To address hypothesis , propose follow aim : Aim # 1 : To investigate efficacy FAHF-2TM food allergy ( addition current food allergen avoidance ) . Aim # 2 : To characterize immunomodulatory effect FAHF-2TM food allergic patient</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<criteria>Male female subject age 12 45 year age otherwise good health determine medical history physical examination History allergy peanut , tree nut , sesame , fish shellfish document positive skin test and/or food allergenspecific IgE level . The subject agree participate study subject 's parent legal guardian willing able give write informed consent , pediatric subject give assent participation study . Positive doubleblind placebo control food challenge peanut , tree nut , sesame , fish , shellfish . Females childbearing potential must inactive sexually take effective birth control measure , deem appropriate investigator , duration study History lifethreatening anaphylaxis peanut , tree nut , sesame , fish shellfish ( involve hypotension require mechanical ventilation ) Allergy corn Acute febrile illness ( cold , flu , etc . ) within one week administration study drug Any history systemic disease investigator 's opinion would preclude subject participate study , e.g . autoimmune disease , neoplasms , HIV hepatitis virus infection Allergic gastrointestinal disease ( e.g . allergic eosinophilic esophagitis/gastroenteritis Abnormal hepatic function ( ALT/AST bilirubin &gt; 1.25 x upper limit normal ) Abnormal bone marrow function ( WBC &lt; 4 x 103/mm3 ; platelet &lt; 100 x 103/mm3 ; hgb &lt; 11 g/dl ) Abnormal renal function ( BUN creatinine &gt; 1.25 x upper limit normal ) Clinically significant abnormal electrocardiogram Current uncontrolled moderate severe asthma define : 1 . FEV1 value &lt; 80 % predict clinical feature moderate severe persistent asthma baseline severity ( defined 2007 NHLBI Guidelines ) great high daily dos inhale corticosteroid ( defined child adult use dose table 2007 NHLBI Guidelines ) . 2 . Use steroid medication follow manner : history daily oral steroid dose &gt; 1 month past year , burst steroid course past 6 month , &gt; 1 burst oral steroid course past year . 3 . Asthma require &gt; 1 hospitalization past year asthma &gt; 1 ED visit past 6 month asthma . Participation another experimental therapy study within 30 day study History alcohol drug abuse Currently take antidepressant medication Pregnant lactate female subject . Females childbearing potential need negative serum pregnancy test screening consider study Use omalizumab Use beta blocker , ACE inhibitor , ARB , calcium channel blocker , history ischemic heart disease Inability discontinue use antihistamine skin test oral food challenge Inability take tablet</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Food allergy</keyword>
	<keyword>Chinese Herbs</keyword>
	<keyword>Investigational new drug</keyword>
	<keyword>Herbs</keyword>
	<keyword>Therapeutic medicine</keyword>
	<keyword>Traditional Chinese medicine</keyword>
</DOC>